Itau Unibanco Holding S.A.’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-600	Closed	-$8K	–	843
2019 Q1	$8K	Hold	600	–	–	﹤0.01%	579
2018 Q4	$8K	Sell	600 -46	-7%	-$919	﹤0.01%	579
2018 Q3	$24K	Sell	646 -16	-2%	-$514	﹤0.01%	566
2018 Q2	$23K	Sell	662 -5	-0.7%	-$192	﹤0.01%	664
2018 Q1	$31K	Buy	667 +456	+216%	+$16.7K	﹤0.01%	508
2017 Q4	$8K	Sell	211 -74	-26%	-$3.23K	﹤0.01%	529
2017 Q3	$48K	Sell	285 -459	-62%	-$27.3K	﹤0.01%	590
2017 Q2	$42K	Buy	744 +676	+994%	+$33.9K	﹤0.01%	310
2017 Q1	$4K	Buy	+68	New	+$3.84K	﹤0.01%	663

Other funds holding KDNY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Itau Unibanco Holding S.A.'s KDNY Position: Q2 2019 in Review

Itau Unibanco Holding S.A. sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q2 2019, closing a stake of 600 shares — an estimated $8K sold.

Itau Unibanco Holding S.A. first reported a position in KDNY in Q1 2017 and held it in 9 quarters. The position peaked at $48K in Q3 2017. 97 funds tracked by Wall St. Rank hold KDNY as of Q2 2019.

Itau Unibanco Holding S.A. reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 600 Chinook Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $8K.
Itau Unibanco Holding S.A. first reported a position in Chinook Therapeutics, Inc. Common Stock in Q1 2017 and held it in 9 quarters.
Itau Unibanco Holding S.A.'s Chinook Therapeutics, Inc. Common Stock position peaked at $48K in Q3 2017.
97 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2019, filed 14 Aug 2019.